Prolonged Sera Incubation to Improve Sensitivity of Double-Immunofluorescent Monoclonal BISL-32 FITC–Protein A Assay

Karp, Moshe; Rabizadh, Albert; Eisenbarth, George S

doi:10.2337/diacare.10.4.535

Article navigation

Letters and Comments| July 01 1987

Prolonged Sera Incubation to Improve Sensitivity of Double-Immunofluorescent Monoclonal BISL-32 FITC–Protein A Assay

Moshe Karp, MD;

Moshe Karp, MD

Joslin Diabetes Center, Harvard Medical School, Brigham and Women's Hospital, and New England Deaconess Hospital

Boston, Massachusetts

Search for other works by this author on:

This Site

PubMed

Google Scholar

Albert Rabizadh, MD;

Albert Rabizadh, MD

Joslin Diabetes Center, Harvard Medical School, Brigham and Women's Hospital, and New England Deaconess Hospital

Boston, Massachusetts

Search for other works by this author on:

This Site

PubMed

Google Scholar

George S Eisenbarth, MD, PhD

Joslin Diabetes Center, Harvard Medical School, Brigham and Women's Hospital, and New England Deaconess Hospital

Boston, Massachusetts

Search for other works by this author on:

This Site

PubMed

Google Scholar

Address correspondence and reprint requests to Moshe Karp, MD, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215.

Diabetes Care 1987;10(4):535–536

https://doi.org/10.2337/diacare.10.4.535

PubMed:

3304901

Prolonged Sera Incubation to Improve Sensitivity of Double-Immunofluorescent Monoclonal BISL-32 FITC–Protein A Assay

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Prolonged Sera Incubation to Improve Sensitivity of Double-Immunofluorescent Monoclonal BISL-32 FITC–Protein A Assay Free

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only

Prolonged Sera Incubation to Improve Sensitivity of Double-Immunofluorescent Monoclonal BISL-32 FITC–Protein A Assay